Trial intelligence / Profile preview

5-fluorouracil cream versus 5-fluorouracil nanofiber dressings with or without rosemary extract for actinic keratosis

IRCT20210118050067N1Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-blind trial of fluorouracil in actinic keratosis (AK) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Investigator global improvement score. Started Feb 2021; status: completed.

02

Drugs

fluorouracil
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on IRCT20210118050067N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210118050067N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call